Luciano N. Mengatto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Luciano N. Mengatto has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Julio A. Luna
Instituto de Desarrollo Tecnológico para la Industria Química (UNL-CONICET), Predio CCT CONICET Santa Fe, RN 168, Santa Fe 3000, Argentina
6 shared publications- Federico Karp
Centro de Investigación y Desarrollo en Fermentaciones Industriales (CINDEFI), Departamento de Química, Facultad de Ciencias Exactas, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
4 shared publications - Germán Abel Islan
Centro de Investigación y Desarrollo en Fermentaciones Industriales (CINDEFI), Departamento de Química, Facultad de Ciencias Exactas, Universidad Nacional de La Plata and CONICET, La Plata, Argentina
3 shared publications Julio A Luna
Instituto de Desarrollo Tecnológico para la Industria Química (INTEC), Universidad Nacional del Litoral-CONICET, Santa Fe, Argentina
3 shared publicationsNatalia S. Velázquez
Instituto de Desarrollo Tecnológico para la Industria Química (INTEC), Universidad Nacional del Litoral-Consejo Nacional de Investigaciones Científicas y Técnicas (UNL-CONICET), Centro Científico Tecnológico, Colectora Ruta Nacional 168, Paraje El Pozo, Santa Fe, Argentina
3 shared publications- Ludmila N. Turino
Instituto de Desarrollo Tecnológico para la Industria Química (UNL-CONICET), Predio CCT CONICET Santa Fe, RN 168, Santa Fe 3000, Argentina
2 shared publications
Latest Publications
- Open Access
- 18 May 2026
- Published by Universidad Nacional de La Plata in Investigaciones Básicas y Aplicadas en Alimentos
- No. 3,p. e015
Encapsulación de hemoglobina en micropartículas a base de ovoproteínas y carragenano, generadas por microfluídica: retención y liberación de hierro y evaluación in vitro
Este trabajo evalúa el uso de tecnología microfluídica para la encapsulación de hemoglobina bovina en polvo como fuente de hierro hemínico, con el objetivo de mejorar estrategias de suplementación. Para la generación de micropartículas se utilizó un dispositivo microfluídico con juntura en cruz, empleando aceite de oliva como fase continua y una mezcla de clara de huevo/κ-carragenato en solución como fase dispersa. Las microgotas se irradiaron con microondas (900 W de potencia, 15 s). Las micropartículas obtenidas presentaron morfología esférica y su distribución de tamaño resultó monodispersa, con un diámetro promedio de 203 µm. El sistema mostró una adecuada retención de hierro, sin detectarse migración hacia la fase continua. La liberación in vitro en condiciones simuladas de pH gastrointestinal alcanzó aproximadamente un 24 % a las 72 h, con un mecanismo controlado por difusión. Los ensayos de citotoxicidad en células Caco-2 indicaron ausencia de efectos adversos, con una viabilidad cercana al 100 %. Los estudios de permeabilidad mostraron que alrededor del 11.6 % del hierro liberado atravesó la monocapa celular. Estos resultados evidencian la viabilidad de sistemas microfluídicos para la administración de hierro hemínico, aunque se requiere optimización para mejorar su liberación y permeabilidad in vitro.
- 18 May 2026
- Published by Universidad Nacional de La Plata in Investigaciones Básicas y Aplicadas en Alimentos
- No. 3,p. e015
Open AccessEncapsulación de hemoglobina en micropartículas a base de ovoproteínas y carragenano, generadas por microfluídica: retención y liberación de hierro y evaluación in vitro
Este trabajo evalúa el uso de tecnología microfluídica para la encapsulación de hemoglobina bovina en polvo como fuente de hierro hemínico, con el objetivo de mejorar estrategias de suplementación. Para la generación de micropartículas se utilizó un dispositivo microfluídico con juntura en cruz, empleando aceite de oliva como fase continua y una mezcla de clara de huevo/κ-carragenato en solución como fase dispersa. Las microgotas se irradiaron con microondas (900 W de potencia, 15 s). Las micropartículas obtenidas presentaron morfología esférica y su distribución de tamaño resultó monodispersa, con un diámetro promedio de 203 µm. El sistema mostró una adecuada retención de hierro, sin detectarse migración hacia la fase continua. La liberación in vitro en condiciones simuladas de pH gastrointestinal alcanzó aproximadamente un 24 % a las 72 h, con un mecanismo controlado por difusión. Los ensayos de citotoxicidad en células Caco-2 indicaron ausencia de efectos adversos, con una viabilidad cercana al 100 %. Los estudios de permeabilidad mostraron que alrededor del 11.6 % del hierro liberado atravesó la monocapa celular. Estos resultados evidencian la viabilidad de sistemas microfluídicos para la administración de hierro hemínico, aunque se requiere optimización para mejorar su liberación y permeabilidad in vitro.
- 26 September 2025
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 114 (12) , 104014
Progesterone-PLGA in situ formed implants: Structural parameters correlations with in vitro and in vivo mathematical models
- 26 September 2025
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 114 (12) , 104014
Progesterone-PLGA in situ formed implants: Structural parameters correlations with in vitro and in vivo mathematical models
- Open Access
- 24 September 2025
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 114
3D-printed biopolymer matrices for the vehiculization and controlled release of octenidine in wound antibiotic therapy
- 24 September 2025
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 114
Open Access3D-printed biopolymer matrices for the vehiculization and controlled release of octenidine in wound antibiotic therapy
- 30 October 2024
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 142 (5)
Dual drug delivery systems based on natural and synthetic polymer particles for isoniazid and rifampicin vehiculization
The purpose of this work is the design and characterization of novel systems based on micro and nanoparticles prepared from poly(lactic‐co‐glycolic) acid (PLGA), chitosan (CHT) and gelatin (GEL) for compartmentalization and dual release of rifampicin and isoniazid. The emulsion/evaporation method is employed for the preparation of PLGA based microparticles and nanoparticles. CHT and GEL are used for the preparation of microparticles by spray‐drying. Entrapment efficiencies are in the range of 35%–73% and 5%–29% for rifampicin and isoniazid in PLGA microparticles, respectively. For isoniazid GEL:CHT particles the entrapment efficiencies are within 82%–100%. Isoniazid shows a complete release at acid condition from GEL:CHT particles, while rifampicin release is maintained from GEL:CHT particles or displays an slightly increase from PLGA particles during buffer conditions. Antimycobacterial activity experiments show that the formulations present the ability to inhibit the bacterial growth in comparison with a control culture without treatment. Rifampicin PLGA and isoniazid GEL:CHT microparticles could be used for the preparation of a dual drug delivery system with each antibiotic in a single particulate compartment. GEL:CHT microparticles containing free isoniazid and rifampicin PLGA nanoparticles are a novel two compartment delivery system.
- 30 October 2024
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 142 (5)
Dual drug delivery systems based on natural and synthetic polymer particles for isoniazid and rifampicin vehiculization
The purpose of this work is the design and characterization of novel systems based on micro and nanoparticles prepared from poly(lactic‐co‐glycolic) acid (PLGA), chitosan (CHT) and gelatin (GEL) for compartmentalization and dual release of rifampicin and isoniazid. The emulsion/evaporation method is employed for the preparation of PLGA based microparticles and nanoparticles. CHT and GEL are used for the preparation of microparticles by spray‐drying. Entrapment efficiencies are in the range of 35%–73% and 5%–29% for rifampicin and isoniazid in PLGA microparticles, respectively. For isoniazid GEL:CHT particles the entrapment efficiencies are within 82%–100%. Isoniazid shows a complete release at acid condition from GEL:CHT particles, while rifampicin release is maintained from GEL:CHT particles or displays an slightly increase from PLGA particles during buffer conditions. Antimycobacterial activity experiments show that the formulations present the ability to inhibit the bacterial growth in comparison with a control culture without treatment. Rifampicin PLGA and isoniazid GEL:CHT microparticles could be used for the preparation of a dual drug delivery system with each antibiotic in a single particulate compartment. GEL:CHT microparticles containing free isoniazid and rifampicin PLGA nanoparticles are a novel two compartment delivery system.
- 1 December 2019
- Published by Elsevier in Carbohydrate Research
- Vol. 486, 107828
Paclitaxel/β-Cyclodextrin interactions, a perspective from pulsed NMR spectroscopy experiments
- 1 December 2019
- Published by Elsevier in Carbohydrate Research
- Vol. 486, 107828
Paclitaxel/β-Cyclodextrin interactions, a perspective from pulsed NMR spectroscopy experiments
- Open Access
- 1 December 2019
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 27 (8) , 1096-1106
Progesterone loaded thermosensitive hydrogel for vaginal application: Formulation and in vitro comparison with commercial product
Progesterone (PGT) is a natural hormone that stimulates and regulates various important functions, such as the preparation of the female body for conception and pregnancy. Due to its low water solubility, it is administered in a micronized form and/or in vehicles with specific solvents requirements. In order to improve the drug solubility, inclusion complexes of PGT and β-cyclodextrins were obtained by the freeze-drying method. Two β-cyclodextrins (native and methylated) in two solvents (water and water:ethanol) and different molar ratio of the reagents were the variables tested for the selection of the best condition for the preparation of the complexes. The PGT/randomly methylated-β-cyclodextrin complexes were incorporated into chitosan thermosensitive hydrogels, as an alternative formulation for the vaginal administration of PGT. Neither the micro and macroscopic characteristics of the gels nor the transition time from solution to gel were modified after the complexes incorporation. In addition, chitosan gels with complexes resisted better the degradation in simulated vaginal fluid in comparison to commercial gel (Crinone®). The chitosan gel with inclusion complexes and Crinone® were tested in vitro in a diffusion assay to evaluate the delivery of the hormone and its diffusion through porcine epithelial mucosa obtained from vaginal tissue. Chitosan gel presented sustained diffusion similar to the exhibited by commercial gel. The use of chitosan gels with inclusion complexes based on cyclodextrins would be a viable alternative for vaginal administration of PGT.
- 1 December 2019
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 27 (8) , 1096-1106
Open AccessProgesterone loaded thermosensitive hydrogel for vaginal application: Formulation and in vitro comparison with commercial product
Progesterone (PGT) is a natural hormone that stimulates and regulates various important functions, such as the preparation of the female body for conception and pregnancy. Due to its low water solubility, it is administered in a micronized form and/or in vehicles with specific solvents requirements. In order to improve the drug solubility, inclusion complexes of PGT and β-cyclodextrins were obtained by the freeze-drying method. Two β-cyclodextrins (native and methylated) in two solvents (water and water:ethanol) and different molar ratio of the reagents were the variables tested for the selection of the best condition for the preparation of the complexes. The PGT/randomly methylated-β-cyclodextrin complexes were incorporated into chitosan thermosensitive hydrogels, as an alternative formulation for the vaginal administration of PGT. Neither the micro and macroscopic characteristics of the gels nor the transition time from solution to gel were modified after the complexes incorporation. In addition, chitosan gels with complexes resisted better the degradation in simulated vaginal fluid in comparison to commercial gel (Crinone®). The chitosan gel with inclusion complexes and Crinone® were tested in vitro in a diffusion assay to evaluate the delivery of the hormone and its diffusion through porcine epithelial mucosa obtained from vaginal tissue. Chitosan gel presented sustained diffusion similar to the exhibited by commercial gel. The use of chitosan gels with inclusion complexes based on cyclodextrins would be a viable alternative for vaginal administration of PGT.
- 4 September 2018
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 70 (11) , 1494-1502
Paclitaxel delivery system based on poly(lactide-co-glycolide) microparticles and chitosan thermo-sensitive gel for mammary adenocarcinoma treatment
Objectives: To evaluate the combination of more than one release system in the same formulation as a useful strategy to achieve paclitaxel delivery in a more sustained and controlled manner. Methods: The present study deals with the preparation of poly(lactide-co-glycolide) microparticles loaded with paclitaxel and included in a chitosan thermo-sensitive gelling solution. The microparticles were characterized by their size, shape and drug loading. The formulation was characterized by scanning electron microscopy, in vitro release experiments and was evaluated in mice bearing mammary adenocarcinoma. Key findings: The formation of paclitaxel crystals in a pharmaceutical formulation reduces its efficacy. In this work, the use of microparticles avoided this phenomenon. Combining more than one delivery system allowed delivering paclitaxel in a more sustained and controlled manner leading to a long-term effect in the site of action. The formulation showed an inhibition in tumour volume of 63.0% in comparison with the control group. Conclusions: One intratumour injection of gelling solution containing the microparticles was at least as efficacious as four intraperitoneal injections of a commercial formulation. In addition, the delivery system was nontoxic, and the treated mice presented the highest percentage of tumour regression and median survival time.
- 4 September 2018
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 70 (11) , 1494-1502
Paclitaxel delivery system based on poly(lactide-co-glycolide) microparticles and chitosan thermo-sensitive gel for mammary adenocarcinoma treatment
Objectives: To evaluate the combination of more than one release system in the same formulation as a useful strategy to achieve paclitaxel delivery in a more sustained and controlled manner. Methods: The present study deals with the preparation of poly(lactide-co-glycolide) microparticles loaded with paclitaxel and included in a chitosan thermo-sensitive gelling solution. The microparticles were characterized by their size, shape and drug loading. The formulation was characterized by scanning electron microscopy, in vitro release experiments and was evaluated in mice bearing mammary adenocarcinoma. Key findings: The formation of paclitaxel crystals in a pharmaceutical formulation reduces its efficacy. In this work, the use of microparticles avoided this phenomenon. Combining more than one delivery system allowed delivering paclitaxel in a more sustained and controlled manner leading to a long-term effect in the site of action. The formulation showed an inhibition in tumour volume of 63.0% in comparison with the control group. Conclusions: One intratumour injection of gelling solution containing the microparticles was at least as efficacious as four intraperitoneal injections of a commercial formulation. In addition, the delivery system was nontoxic, and the treated mice presented the highest percentage of tumour regression and median survival time.
- 15 September 2017
- Published by SAGE Publications in Journal of Elastomers & Plastics
- Vol. 50 (5) , 391-402
Recyclable amitraz-ethylene vinyl acetate strips used for beehives treatment against Varroa destructor
In this work, a new recyclable ethylene-vinyl acetate (EVA)-based strip impregnated with amitraz (AMZ) was prepared, characterized, and evaluated for the treatment of Apis mellifera against Varroa destructor. Bees are important for natural pollination, honey, and related goods production. Varroa destructor is currently considered one of the major pests and important efforts around the world are focused on methods for varroasis treatment. The procedure of strips preparation presented in this work consisted of two steps: impregnation and molding of impregnated pellets. Differential scanning calorimetry and gas chromatography–mass spectrometry analyses confirmed that AMZ molecule resisted the impregnation and molding conditions. The strips were sufficiently strong to resist destruction by the bees. The final infestation was lower in the hives treated with AMZ/EVA strips than in those treated with commercial strips. In order to check the possibility of recycling, strips were cut into little pieces and were subjected to total AMZ extraction. Finally, the fragments were exposed to re-impregnation and molding. The strips prepared after the recycling process presented the same shape and AMZ load than fresh strips.
- 15 September 2017
- Published by SAGE Publications in Journal of Elastomers & Plastics
- Vol. 50 (5) , 391-402
Recyclable amitraz-ethylene vinyl acetate strips used for beehives treatment against Varroa destructor
In this work, a new recyclable ethylene-vinyl acetate (EVA)-based strip impregnated with amitraz (AMZ) was prepared, characterized, and evaluated for the treatment of Apis mellifera against Varroa destructor. Bees are important for natural pollination, honey, and related goods production. Varroa destructor is currently considered one of the major pests and important efforts around the world are focused on methods for varroasis treatment. The procedure of strips preparation presented in this work consisted of two steps: impregnation and molding of impregnated pellets. Differential scanning calorimetry and gas chromatography–mass spectrometry analyses confirmed that AMZ molecule resisted the impregnation and molding conditions. The strips were sufficiently strong to resist destruction by the bees. The final infestation was lower in the hives treated with AMZ/EVA strips than in those treated with commercial strips. In order to check the possibility of recycling, strips were cut into little pieces and were subjected to total AMZ extraction. Finally, the fragments were exposed to re-impregnation and molding. The strips prepared after the recycling process presented the same shape and AMZ load than fresh strips.
- 7 September 2016
- Published by Springer Nature in Iranian Polymer Journal
- Vol. 25 (11) , 897-906
Application of simultaneous multiple response optimization in the preparation of thermosensitive chitosan/glycerophosphate hydrogels
- 7 September 2016
- Published by Springer Nature in Iranian Polymer Journal
- Vol. 25 (11) , 897-906
Application of simultaneous multiple response optimization in the preparation of thermosensitive chitosan/glycerophosphate hydrogels